|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Genetic & Cell Therapies in Cardiovascular Disease | ||||||||||||||||
January 28, 2003 | ||||||||||||||||
Mayo Clinic, Rochester, MN October 24 - 26, 2003 This course aims to explore the advances of cell and gene therapies for cardiovascular diseases. Currently, many opportunities exist for the use of these novel approaches to treat patients with cardiovascular disease. This course will provide information regarding advances in preclinical and clincal studies of gene transfer. Areas of opportunities as well as challenges will be discussed in full and the relevance will be to trainees as well as to practicing physicians and scientists. The use of autologous cell based therapy for cardiovascular diseases has been recently established. The comparisons between the types of cells that might be available as well as their therapeutic potential will be discussed. Advances in preclinical studies using these cells will be fully explored. |
||||||||||||||||
Organized by: | Robert Simari, M.D. and Noel Caplice, M.D. | |||||||||||||||
Invited Speakers: | Stefanie Dimmeler, M.D. Robert P. Hebbel, M.D. Jan Rozing, M.D. Michael D. Schneider, M.D. Catherine M. Verfaillie, M.D. Andreas M. Zeiher, M.D. Keith March, M.D., Ph.D. Eduardo Marban, M.D. Walter Koch, Ph.D. Edith Tzeng, M.D. |
|||||||||||||||
Deadline for Abstracts: | August 1, 2003 | |||||||||||||||
Registration: | Mayo Clinic Cardiovascular CME 200 First Street SW - GO-06-138SW Rochester, MN 55905 P: 507-266-0677 or 1-800-283-6296 F: 507-538-0146 | |||||||||||||||
E-mail: | CVCME@mayo.edu | |||||||||||||||
Posted by: | Deborah Feils | |||||||||||||||
Host: | cache1.mayo.edu | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |